Home » Stocks » SIEN

Sientra, Inc. (SIEN)

Stock Price: $6.29 USD 0.12 (1.94%)
Updated May 13, 2021 4:00 PM EDT - Market closed
After-hours: $6.30 +0.01 (0.16%) May 13, 4:20 PM
Market Cap 349.44M
Revenue (ttm) 77.55M
Net Income (ttm) -116.03M
Shares Out 54.32M
EPS (ttm) -2.27
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day May 13
Last Price $6.29
Previous Close $6.17
Change ($) 0.12
Change (%) 1.94%
Day's Open 6.26
Day's Range 6.00 - 6.35
Day's Volume 1,520,105
52-Week Range 2.33 - 8.93

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

SANTA BARBARA, Calif., May 11, 2021 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today announced its ...

2 days ago - GlobeNewsWire

Transaction Enables Sharper Focus on Company's Rapidly Growing Breast Product Business Transaction Enables Sharper Focus on Company's Rapidly Growing Breast Product Business

2 days ago - GlobeNewsWire

On Tuesday, May 11, Sientra (NASDAQ:SIEN) will release its latest earnings report. Decipher the announcement with Benzinga's help.

3 days ago - Benzinga

Sientra (SIEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 week ago - Zacks Investment Research

The partnership builds on Sientra's safety profile by empowering surgeons with Butterfly Network's cutting-edge point-of-care ultrasound technology to screen and evaluate patients with breast implants T...

1 week ago - GlobeNewsWire

Investors often look to top fund managers to glean information on the best strategies and generate new investment ideas.

Other stocks mentioned: ABNB, ASML, BGNE, CYH, GS, SEAS
1 month ago - GuruFocus

Sientra (SIEN) delivered earnings and revenue surprises of -15.15% and 0.20%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

SANTA BARBARA, Calif., March 11, 2021 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today announced it...

2 months ago - GlobeNewsWire

SANTA BARBARA, Calif., March 11, 2021 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today announced th...

2 months ago - GlobeNewsWire

Sientra (NASDAQ:SIEN) announces its next round of earnings this Thursday, March 11. Here is Benzinga's look at Sientra's Q4 earnings report.

2 months ago - Benzinga

Sientra (SIEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 months ago - Zacks Investment Research

SANTA BARBARA, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today announced tha...

2 months ago - GlobeNewsWire

SANTA BARBARA, Calif., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today announced the...

3 months ago - GlobeNewsWire

Sientra Inc (NASDAQ: SIEN) prices its previously announced underwritten public offering of 5.4 million common shares at $6.75 per share, with gross proceeds of approximately $36.5 million. The offer pri...

3 months ago - Benzinga

SANTA BARBARA, Calif., Feb. 08, 2021 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today announced the...

3 months ago - GlobeNewsWire

SANTA BARBARA, Calif., Feb. 08, 2021 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today announced tha...

3 months ago - GlobeNewsWire

The company released preliminary results for its fourth quarter.

3 months ago - The Motley Fool

Estimates highest ever Breast Products segment net sales of $17.9 million, representing 40% year over year growth

3 months ago - GlobeNewsWire

Sientra, Inc. (SIEN) CEO Ron Menezes on Q3 2020 Results - Earnings Call Transcript

6 months ago - Seeking Alpha

Sientra (SIEN) delivered earnings and revenue surprises of 13.16% and 38.92%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

6 months ago - Zacks Investment Research

Reports record Breast Products net sales of $15.3 million, representing 54% sequential growth and 2 1 % year over year growth

6 months ago - GlobeNewsWire

Jeffrey Nugent, Current Chairman and Chief Executive Officer, Announces His Retirement

6 months ago - GlobeNewsWire

SANTA BARBARA, Calif., Nov. 06, 2020 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a diversified medical aesthetics company, today announced that members of management a...

6 months ago - GlobeNewsWire

Sientra (SIEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

6 months ago - Zacks Investment Research

SANTA BARBARA, Calif., Oct. 20, 2020 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a diversified medical aesthetics company, today announced that it will release financi...

6 months ago - GlobeNewsWire

Marks First Regulatory approval of Sientra Breast Implants Outside of the U.S. Marks First Regulatory approval of Sientra Breast Implants Outside of the U.S.

8 months ago - GlobeNewsWire

While most of Wall Street focuses on large and mega-cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy.

Other stocks mentioned: APTX, CBAY, EOLS, IBIO
8 months ago - 24/7 Wall Street

Sientra, Inc. (SIEN) CEO Jeffrey Nugent on Q2 2020 Results - Earnings Call Transcript

9 months ago - Seeking Alpha

Sientra (SIEN) delivered earnings and revenue surprises of 15.56% and 40.40%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

9 months ago - Zacks Investment Research

Continued Strength in Core Breast Products Business Despite COVID-19 Headwinds

9 months ago - GlobeNewsWire

SANTA BARBARA, Calif., July 29, 2020 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN), a medical aesthetics company, announced today the company will be participating in the upcoming virtual Canaccord...

9 months ago - GlobeNewsWire

SANTA BARBARA, Calif., July 27, 2020 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a diversified medical aesthetics company, today announced that it will release finan...

9 months ago - GlobeNewsWire

SANTA BARBARA, Calif., July 14, 2020 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN), a medical aesthetics company, announced today that Jeff Nugent, President and Chief Executive Officer, will parti...

9 months ago - GlobeNewsWire

Sientra, Inc. (SIEN) CEO Jeffrey Nugent on Q1 2020 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Sientra (SIEN) delivered earnings and revenue surprises of 10.20% and -9.46%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

1 year ago - Zacks Investment Research

Investors need to pay close attention to Sientra (SIEN) stock based on the movements in the options market lately.

1 year ago - Zacks Investment Research

Sientra, Inc. (SIEN) CEO Jeff Nugent on Q4 2019 - Earnings Call Transcript

1 year ago - Seeking Alpha

Sientra (SIEN) delivered earnings and revenue surprises of 7.14% and 0.04%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

1 year ago - Zacks Investment Research

SANTA BARBARA, Calif., Feb. 19, 2020 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company, today announced that on February 13, 2020, the Compens...

1 year ago - GlobeNewsWire

SANTA BARBARA, Calif., Dec. 16, 2019 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN), a medical aesthetics company, today announced that on December 3, 2019, the Compensation Committee of the Company...

1 year ago - GlobeNewsWire

Aesthetics surgery is a big market, and these three companies are positioned to win from its growth.

Other stocks mentioned: CUTR, INMD
1 year ago - The Motley Fool

What should investors think of Sientra after its impressive Q3 results?

1 year ago - The Motley Fool

Sientra's (SIEN) CEO Jeff Nugent on Q3 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Shares pop after the company reports impressive third-quarter results.

1 year ago - The Motley Fool

SANTA BARBARA, Calif., Oct. 31, 2019 (GLOBE NEWSWIRE) -- Sientra, Inc. (Nasdaq: SIEN), a medical aesthetics company, announced today that its management team will participate in the following upcoming...

1 year ago - GlobeNewsWire

As breast implant-related health hazards surface, a few manufacturing companies might bear a brunt.

Other stocks mentioned: AGN, JNJ
1 year ago - Zacks Investment Research

As breast implant-related health hazards surface, a few manufacturing companies might bear a brunt.

Other stocks mentioned: AGN, JNJ
1 year ago - Zacks Investment Research

SANTA BARBARA, Calif., Sept. 17, 2019 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN), a medical aesthetics company, today announced that on September 12, 2019, the Compensation Committee of the Comp...

1 year ago - GlobeNewsWire

While most of Wall Street focuses on large and mega cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy.

Other stocks mentioned: CPE, GLMD, TELL, VKTX
1 year ago - 24/7 Wall Street

While most of Wall Street focuses on large and mega cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy.

Other stocks mentioned: ECA, EVH, FLMN, VSLR
1 year ago - 24/7 Wall Street

About SIEN

Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products to plastic surgeons in the United States and internationally. It operates through two segments, Breast Products and miraDry. The company offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names. It also provides body contouring products; facial and nasal implants; saline filled br... [Read more...]

Industry
Medical Devices
IPO Date
Oct 29, 2014
CEO
Jeffrey Nugent
Employees
255
Stock Exchange
NASDAQ
Ticker Symbol
SIEN
Full Company Profile

Financial Performance

In 2020, Sientra's revenue was $71.24 million, a decrease of -14.88% compared to the previous year's $83.70 million. Losses were -$89.95 million, -15.79% less than in 2019.

Financial Statements

Analyst Forecasts

According to 8 analysts, the average rating for Sientra stock is "Strong Buy." The 12-month stock price forecast is 10.71, which is an increase of 70.27% from the latest price.

Price Target
$10.71
(70.27% upside)
Analyst Consensus: Strong Buy